👉🏼 Please join us this Wednesday May 22! 🩺💻
Free educational webinar #lymphoma #lymsm #HodgkinLymphoma
Register here 🔗us06web.zoom.us/webinar/regist…
With thanks to Lymphoma Australia

Published in HemaSphere Journal (IF = 9.1) today! Treatment outcomes in patients with large B‐cell lymphoma after progression to #CART

Great Spain+UK joint effort, big thanks to Andrea Kuhnl Pau Abrisqueta Josu Iraola Truchuelo Victor Navarro and all participating colleagues!

onlinelibrary.wiley.com/doi/full/10.10…

👉🏼 Please join us on this Wednesday!
🩺💻Free educational webinar #hodgkinlymphoma
🔗 us06web.zoom.us/webinar/regist…

😀Algorithm for the classification of aggressive B-cell lymphomas in WHO-HAEM5 according to rearrangements of MYC, BCL2, and BCL6 and/or presence of the complex 11q

ncbi.nlm.nih.gov/pmc/articles/P…
#lymphoma #aggrssive #burkitt

📢 Are you interested in joining our interactive discussion on therapies in B-cell malignancies, co-hosted by the Lymphoma Hub and #MultipleMyeloma Hub at European Hematology Association? Attend and receive 1.5 CME credits of EBAH accreditation!

#EHA2024 #lymsm #mmsm #lymphoma

What is the current treatment landscape for CAR T cell therapies in lymphoma? And how are researchers addressing treatment resistance in patients?

Get insights from our Dr. Sattva Neelapu: brnw.ch/21wJXNE OncLive.com #lymphoma #EndCancer

👉🏼 Please join us on this Wednesday!
🩺💻Free educational webinar #hodgkinlymphoma
🔗 us06web.zoom.us/webinar/regist…

Join @cllsociety on 6/4 at 5:30pm ET, along with Brian Koffman, chadi nabhan MD, MBA, FACP, Alan Skarbnik, Matthew Davids, MD, MMSc, & Adam Kittai, for an X Space event discussing research updates on #CLL from #ASCO2024 x.com/i/spaces/1yokm…  #MedTwitter #HemeOnc

💻🩺Join us this Wed May 22 #WiLingWednesdays free educational webinar #HodgkinLymphoma #lymphoma #lymsm
👉🏼Pls register here🔗 us06web.zoom.us/webinar/regist…
Carla Casulo, MD #SarahRutherfordMD Lymphoma Australia

Don't miss THE annual gathering for the global oncology community. Experience the #ASCO24 world of inspiration online - whenever you want, wherever you are with more than 145 hours of livestream content and everything available on demand after the meeting!

💻🩺Join us this Wed May 22 #WiLingWednesdays free educational webinar #HodgkinLymphoma #lymphoma #lymsm
👉🏼Pls register here🔗 us06web.zoom.us/webinar/regist…
Carla Casulo, MD #SarahRutherfordMD Lymphoma Australia

1 day to go till ALLG's May Scientific Meeting in Adelaide. ALLG Members can still register to attend in-person or virtually. Clinical trial professionals, don’t miss Tuesday's Haematology Education Day with leading AML & CML experts. Register: tinyurl.com/uzjdek3b #ALLGtrials

A post-hoc #analysis , published in Blood Journal, indicates that adults with #relapsed or #refractory large B-cell #lymphoma appeared to have better outcomes when cellular #therapy was given in second line rather than third line. ow.ly/mBWu50RyynT

Highly recommended:
A postdoctoral position available in the group of my colleague, Marc Raaijmakers. If you are interested to work at Hematology, ErasmusMC in Rotterdam, please apply via:
werkenbijerasmusmc.nl/en/vacancy/985…
or mail to
[email protected]
Spread the news!

💻🩺 Join us next Wed May 22 #WiLingWednesdays free educational webinar #HodgkinLymphoma
👉🏼Strategies to tailor HL treatment
Register here 🔗us06web.zoom.us/webinar/regist…
#lymphoma #lymsm Carla Casulo, MD #SarahRutherfordMD Lymphoma Australia

#lymphoma #EmergingWiL #lymsm

▶️▶️Check out new paper in Blood Journal
No RCTs of BTKi monotherapy vs ICT in R/R MCL
Malinverni et al
Large 🇪🇺🇬🇧 collaboration
BTKi monotherapy still improves survival outcomes vs ICT in 385 younger pts with later POD >24m post 1L treatment #MCL #lymsm
ashpublications.org/blood/article-…

#lymphoma #EmergingWiL #lymsm

Your meeting, your schedule. The 2024 ASCO Annual Meeting offers more than 145 hours of livestream and on-demand session content, so you can make the most of your meeting experience. #ASCO24

Chemoimmunotherapy with R-CHOP provides good survival outcomes and a low rate of relapse in stage 1 primary gastric diffuse large B-cell #lymphoma , according to a study including Australian researchers Chan Cheah Michael Dickinson
British Journal of Haematology
thelimbic.com/haematology/r-…